Document Detail


Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study.
MedLine Citation:
PMID:  17342649     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P=.001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.
Authors:
Roy F Chemaly; Harrys A Torres; Elizabeth A Aguilera; Gloria Mattiuzzi; Maria Cabanillas; Hagop Kantarjian; Virginia Gonzalez; Amar Safdar; Issam I Raad
Related Documents :
15136219 - Levels of minimal residual disease detected by quantitative molecular monitoring herald...
10487829 - Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry...
6897059 - Lymphoblastic lymphoma: cytogenetic, pathologic, and immunologic studies.
7656199 - Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma.
1000019 - Is there evidence for subclasses of chronic lymphocytic leukemia? a study using numeric...
7854769 - Intracellular glutathione content in leukemias.
4063189 - Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.
7018639 - Outpatient flexible fibreoptic sigmoidoscopy, diagnostic yield and the value of glucagon.
8457789 - Recombinant human erythropoietin and the anemia of multiple myeloma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-02-14
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  44     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-07     Completed Date:  2007-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  964-7     Citation Subset:  IM    
Affiliation:
Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1402, USA. rfchemaly@mdanderson.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antiviral Agents / therapeutic use*
Cohort Studies
Comorbidity
Female
Follow-Up Studies
Humans
Influenza, Human / diagnosis,  drug therapy*,  epidemiology*
Leukemia, Myeloid / diagnosis,  epidemiology*
Male
Middle Aged
Neuraminidase / antagonists & inhibitors*,  therapeutic use
Probability
Retrospective Studies
Risk Assessment
Survival Rate
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antiviral Agents; EC 3.2.1.18/Neuraminidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinica...
Next Document:  A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antig...